LEBOVITS CHAIM (See Remarks) received a stock award from BRAINSTORM CELL THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 3 awards
Filed: 5/14/2024ACC: 0001104659-24-060889
Officer· See Remarks
Since Jul 2018
+40K
Net shares
Net buyer
$18.9K
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
40K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+20K
Price / share
$0.47
Trade value
$9.30K
% of position
1.9%
5/10/2024
1.06M→1.08M
Common Stock
Direct
Shares
+10K
Price / share
$0.47
Trade value
$4.67K
% of position
0.9%
5/11/2024
1.08M→1.09M
Common Stock
Direct
Shares
+10K
Price / share
$0.49
Trade value
$4.90K
% of position
0.9%
5/13/2024
1.09M→1.10M
Total
Net shares
+40K
Net value
$18.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/10/2024 | A · Award | +20K | $0.47 | $9.30K | 1.9% | 1.06M | 1.08M |
| Common Stock Direct | 5/11/2024 | A · Award | +10K | $0.47 | $4.67K | 0.9% | 1.08M | 1.09M |
| Common Stock Direct | 5/13/2024 | A · Award | +10K | $0.49 | $4.90K | 0.9% | 1.09M | 1.10M |
| Total | +40K | $18.86K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2M
Total
2M indirect2M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2M | Indirect |
| Total | 2M | 2M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported